Arterial compliance in obese subjects is improved with dietary plant n- 3 fatty acid from flaxseed oil despite increased LDL oxidizability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1163-1170

  Nestel, Paul J ^a   Pomeroy, Sylvia E ^a   Sasahara, Takayuki ^a   Yamashita, Takeshi ^a   Liang, Yu Lu ^d   Dart, Anthony M ^a   Jennings, Garry L ^a   Abbey, Mavis ^c   Cameron, James D ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c CSIRO   (Australia)

^d NONE

Author keywords

Arterial compliance; Flaxseed oil; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID;

ADULT; ARTERY COMPLIANCE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; DIETARY INTAKE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PLANT SEED; PRIORITY JOURNAL;

EID: 0030923849     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1163     Document Type: Article

References (46)

1. Denke MA, Sempos CT, Grundy SM. Excess body weight: an under-recognized contributor to high blood cholesterol levels in white American men. Arch Intern Med. 1993;153:1093-1103.
2. Manson JE, Colditz GA, Stampfer MJ, Willen WC, Rosner B, Manson RR, Speizer FE, Hennekens CH. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322:882-889.
3. Hubert HB, Manning F, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
4. Hauner H, Bognar E, Blum A. Body fat distribution and its association with metabolic and hormonal risk factors in women with angiographically assessed coronary artery disease: evidence for the presence of a metabolic syndrome. Atherosclerosis. 1994;105:209-216.
5. Larsson B, Bengtsson C, Bjorntorp P, Lapidus L, Sjostrom L, Svardsudd K, Tibblin G, Wedel H, Welin L, Wilhelmsen L. Is abdominal fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol. 1992;135:266-273.
6. Zavaroni I, Bonini L, Fantuzzi M, Dall'aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity, and syndrome X. J Intern Med. 1994;235:51-56.
7. Dart AM, Qi XL. Determinants of arterial stiffness in Chinese migrants to Australia. Atherosclerosis. 1995;117:263-272.
8. McVeigh GE, Brennan GM, Cohn JN, Finkelstein SM, Hayes RJ, Johnston GD. Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus. Arterioscler Thromb. 1994;14:1425-1429.
9. Cameron JD, Dart AM. Exercise training increases total systemic arterial compliance in humans. Am J Physiol. 1994;266:H693-H701.
10. Chin JFP,.Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension. 1993;21:22-28.
11. de Lorgeril M, Renaud S, Mamelle N. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1984;343:1454-1459.
12. Ershow AG, for the DELTA Investigation. Dietary effects on lipoproteins and thrombogenic activity in subjects with markers for insulin resistance (DELTA-2). FASEB J. 1996;10:A462. Abstract.
13. Simon AC, Levenson JA, Levy BY, Bouthier JE, Peronneau PP, Safar ME. Effect of nitroglycerin on peripheral large arteries in hypertension. Br J Clin Pharmacol. 1982;14:241-246.
14. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki M, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 1994;89:2519-2524.
15. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 1995; 332;488-493.
16. Tremoli E, Maderna P, Marangoni F, Colli S, Eligini S, Catalano I, Angeli MT, Pazzucconi F, Gianfranceschi G, Davi G, Stragliotto E, Sirtori CR, Galli C. Prolonged inhibition of platelet aggregation after n-3 fatty acid ethyl ester ingestion by healthy volunteers. Am J Clin Nutr. 1995;61:607-613.
17. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: the Expert Panel. Arch Intern Med. 1988;148:36-69.
18. Composition of Foods Australia (COFA). Canberra, Australia: AGPS; 1989.
19. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
20. Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low-density lipoprotein. Am J Clin Nutr. 1991;53:314S-321S.
21. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-310.
22. Yang CS, Lee MJ. Methodology of plasma retinol, tocopherol and carotenoid assays in cancer prevention studies. J Nutr Growth Cancer. 1987;4:19.
23. Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr. 1993;57:391-398.
24. Liu Z, Brin KP, Yin FC. Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol. 1986;251:H588-H600.
25. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80:1652-1659.
26. Jonnalagadda SS, Mitchell DC, Smicklas-Wright H, Kris-Etherton PM, Van Heel N, Kamally W. Underestimation of energy intake: comparison of self-reported and actual intake. FASEB J. 1996;10:A724. Abstract.
27. Storlien LH, Jenkins AB, Chisholm DJ, Pascoe WS, Khouri S, Kraegen EW. Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and ω-3 fatty acids in muscle phospholipid. Diabetes. 1991;40:280-289.
28. Swinburn BA, Boyce VL, Bergman RN, Howard BV, Bogardus C. Deterioration in carbohydrate metabolism and lipoprotein changes induced by modern, high fat diet in Pima Indians and Caucasians. J Clin Endocrinol Metab, 1991;73:156-165.
29. Salomaa V, Ahola I, Tuomilehto J, Aro A, Pietinen P, Korhonen HJ, Penttila I. Fatty acid composition of serum cholesterol esters in different degrees of glucose intolerance: a population-based study. Metabolism. 1990;39:1285-1291.
30. Garg A, Bonanome A, Grundy SM, Zhang ZJ, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1988;319:829-834.
31. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relationship between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. W Engl J Med. 1993;328:238-244.
32. Lichtenstein AH, Austrian LM, Carrasco W, Jenner JL, Gualtieri LJ, Goldin BR, Ordovas JM, Schaefer EJ. Effects of canola, corn, and olive oils on fasting and postprandial plasma lipoproteins in humans as part of a National Cholesterol Education Program Step 2 diet. Arterioscler Thromb. 1993;13:1533-1542.
33. Kestin M, Clifton P, Belling GB, Nestel PJ. n-3 fatty acids of marine origin lower systolic blood pressure and triglycerides but raise LDL cholesterol compared with n-3 and n-6 fatty acids from plants. Am J Clin Nutr. 1990;51:1028-1034.
34. Mantzioris E, James MJ, Gibson RA, Cleland LG. Dietary substitution with an α-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr. 1994;59:1304-1309.
35. Finkelstein SM, Collins VR, Cohn JN. Arterial vascular compliance response to vasodilators by Fourier and pulse contour analysis. Hypertension. 1988;12:380-387.
36. McVeigh GE, Finkelstein SM, Cohn JN. Assessment of arterial compliance in hypertension. Curr Opin Nephrol Hypertens. 1993;2:82-86.
37. Hamazaki T, Urakaze M, Sawazaki S, Yamazaki K, Taki H, Yano S. Comparison of pulse wave velocity of the aorta between inhabitants of fishing and farming villages in Japan. Atherosclerosis. 1988;73:157-160.
38. Wahlqvist ML, Lo CS, Myers KA. Fish intake and arterial wall characteristics in healthy people and diabetic patients. Lancet. 1989;2:944-946.
39. Chin JPF, Dart AM. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effects of fish oils. Clin Exp Pharmacol Physiol. 1994;21:749-755.
40. Zeiher AM, Schachinger V, Hohnloser SH, Saubier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation. 1994;89:2525-2532.
41. Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages. J Lipid Res. 1995;36:473-484.
42. Nestel PJ. Effects of n-3 fatty acids on lipid metabolism. Annu Rev Nutr. 1990;10:149-167.
43. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyperlipidemic humans with flax seed supplementation: a preliminary report. J Am Coll Nutr. 1993;12:501-504.
44. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Intern Med. 1990;228:165-171.
45. Fasching P, Ratheiser K, Waldhäusl W, Rohac M, Osterrode W, Mowotny P, Vierhapper H. Metabolic effects of fish-oil supplementation in patients with impaired glucose tolerance. Diabetes. 1991;40:583-589.
46. Eritsland J, Arnesen H, Seljeflot I, Høstmark AT. Long-term metabolic effects of n-3 polyunsaturated fatty acids in patients with coronary artery disease. Am J Clin Nutr. 1994;61:831-836.